University awarded $12 million to further develop opioid use disorder drug

September 30, 2024

Charles  P.  France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]

UT Health San Antonio’s Brett Ginsburg selected for Wellcome Leap Untangling Addiction program

August 20, 2024

Study will evaluate biomarkers and novel treatments for alcohol use disorder Brett Ginsburg, PhD, director of the Biochemical Pharmacology Analytical Laboratory at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was selected as a performer with the Wellcome Leap Untangling Addiction program. Wellcome Leap is a U.S.-based nonprofit organization […]

UT Health San Antonio faculty member helps create universal long COVID definition

July 31, 2024

A report released June 11 by the National Academies of Sciences, Engineering and Medicine (NASEM) provides a working definition of long COVID. Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Rehabilitation Medicine in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San […]

Think Science live event: Let’s talk about addiction

July 3, 2024

  Texas Public Radio will partner with The University of Texas Health Science Center at San Antonio (UT Health San Antonio) to serve the community at the next Think Science live Q & A. The event features presentations by experts from UT Health Science Center San Antonio on the latest evidence-based treatments in substance use […]